ERYTECH PHARMA's ticker is ERYP and the CUSIP is 29604W108. A total of 9 filers reported holding ERYTECH PHARMA in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $489,000 | -7.4% | 70,000 | 0.0% | 0.02% | -13.6% |
| Q1 2019 | $528,000 | +8.4% | 70,000 | 0.0% | 0.02% | 0.0% |
| Q4 2018 | $487,000 | -18.3% | 70,000 | 0.0% | 0.02% | -12.0% |
| Q3 2018 | $596,000 | -23.8% | 70,000 | 0.0% | 0.02% | -26.5% |
| Q2 2018 | $782,000 | -46.9% | 70,000 | 0.0% | 0.03% | -55.3% |
| Q1 2018 | $1,472,000 | -4.4% | 70,000 | 0.0% | 0.08% | -8.4% |
| Q4 2017 | $1,539,000 | – | 70,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|